FDA “Black Box” Warning Regarding Use of Droperidol for Postoperative Nausea and Vomiting: Is It Justified?

This publication has 11 references indexed in Scilit:

• How Much Are Patients Willing to Pay to Avoid Postoperative Nausea and Vomiting?
  Published by Wolters Kluwer Health ,2001
• Efficacy, dose-response, and adverse effects of droperidol for prevention of postoperative nausea and vomiting
  Canadian Journal of Anesthesia/Journal canadien d'anesthésie, 2000
• Cost-effectiveness of Prophylactic Antiemetic Therapy with Ondansetron, Droperidol, or Placebo
  Anesthesiology, 2000
• The Cost-effective Management of Postoperative Nausea and Vomiting
  Anesthesiology, 2000
• Postoperative Nausea and Vomiting: Prophylaxis Versus Treatment
  Anesthesia & Analgesia, 1999
• Which Clinical Anesthesia Outcomes Are Important to Avoid? The Perspective of Patients
  Anesthesia & Analgesia, 1999
• A Comparison of the Efficacy, Safety, and Patient Satisfaction of Ondansetron Versus Droperidol as Antiemetics for Elective Outpatient Surgical Procedures
  Anesthesia & Analgesia, 1998
• Efficacy, Dose-Response, and Safety of Ondansetron in Prevention of Postoperative Nausea and Vomiting
  Anesthesiology, 1997
• A Comparison of Costs and Efficacy of Ondansetron and Droperidol as Prophylactic Antiemetic Therapy for Elective Outpatient Gynecologic Procedures
  Anesthesia & Analgesia, 1996
• Cardiac dysrhythmias during oral surgery. Comparison of hyoscine and droperidol premedication
  Anaesthesia, 1986